Highlights Newsletter 2
This newsletter presents you the following key sessions:
3. Nimotuzumab significantly improves overall survival for KRAS wild-type advanced pancreatic cancer
This newsletter presents you the following key sessions:
3. Nimotuzumab significantly improves overall survival for KRAS wild-type advanced pancreatic cancer
Medical writer
Medical writer